Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 6Phase 1/2 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1Breast Neoplasms 1

Interventions

Oxaliplatin 10Endoscopic Mucosal Resection 10Surgical Procedures, Operative 8Standard of Care 8Exercise 7Laparoscopy 6Fluorouracil 6Drug Therapy 6Sodium Chloride 5Leucovorin 5Gastroenterostomy 5Gastrectomy 5Endoscopy, Digestive System 5Saline Solution 4S 1 (combination) 4Preoperative Exercise 4Practice Guidelines as Topic 4Dietary Supplements 4Control Groups 4Biopsy 4Acupuncture Therapy 4Surveys and Questionnaires 3Ropivacaine 3Paclitaxel 3Nutrition Assessment 3Narrow Band Imaging 3Methods 3Indocyanine Green 3Hyperthermic Intraperitoneal Chemotherapy 3Hematologic Tests 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Stomach Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT04047953 2023-04-05

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Peking University Cancer Hospital & Institute

Phase NA Recruiting
95 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡